In terms of mechanism, the decreased expression of kinase C zeta (PKC-ζ) in bone-derived breast cancer cells led to the upregulation of PHGDH, PSAT1 and PSPH, consequently promoted the utilization of glutamine through serine biosynthesis (70). Here, PHGDH is linked to breast carcinoma.